Top Analyst Upgrades and Stocks to Buy: Eli Lilly, W.R. Grace, Intelsat and More

Jon C. Ogg

Investors and traders seem to be constantly looking for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find great ideas from value stocks to growth stocks to dividend stocks. We are breaking out the positive analyst calls as far as stocks to buy and positive research calls today. These are some of this Tuesday’s top analyst upgrades, initiations and positive analyst research calls seen from Wall Street after a three-day weekend.

Eli Lilly & Co. (NYSE: LLY) was raised to Hold from Underperform at Jefferies.

GlaxoSmithKline PLC (NYSE: GSK) was raised to Buy from Hold at Jefferies.

Johnson Controls Inc. (NYSE: JCI) was raised to Outperform from Market Perform at Wells Fargo.

Logitech International S.A. (NASDAQ: LOGI) was raised to Neutral from Underperform at Credit Suisse.

See also: UBS Live Key Call List Features the Top Nine Stocks to Buy Now

Merck & Co. Inc. (NYSE: MRK) was raised to Buy from Hold with $54 price target at Jefferies.

Novo Nordisk A/S (NYSE: NVO) was raised to Hold from Sell at Deutsche Bank.

PSEG Co. (NYSE: PEG) was raised to Neutral from Underperform at Credit Suisse.

See also: Deutsche Bank’s Defensive Food Stocks to Buy

Qiwi PLC (NASDAQ: QIWI) was started as Outperform at Credit Suisse and started as Outperform at William Blair.

W.R. Grace (NYSE: GRA) was put on the Conviction Buy List with a $105 price target at Goldman Sachs.

The quiet period for Intelsat S.A. (NYSE: I) ended and the analysts were mixed to positive: started as Neutral at Credit Suisse, started as Hold at Deutsche Bank, started as Overweight at Evercore Partners and started as Buy at Nomura.

Read also: Top Analyst Downgrades for Tuesday